ANDA 40337, held by Hikma. Trihexyphenidyl Hydrochloride.
As of Nov 16, 2026, ANDA 40337 (Trihexyphenidyl Hydrochloride), held by Hikma, was first approved by FDA on Feb 16, 2000, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 16, 2000 | Original application | Approved |
| Trihexyphenidyl Hydrochloride5MG · tablet;oral | Trihexyphenidyl Hydrochloride | Discontinued |
| Trihexyphenidyl Hydrochloride2MG · tablet;oral | Trihexyphenidyl Hydrochloride | Discontinued |
| Nov 14, 2000 | Supplement 3Manufacturing | Approved | None posted |
| Nov 14, 2000 | Supplement 2Labeling | Approved | None posted |
| Nov 14, 2000 | Supplement 1Manufacturing | Approved | None posted |
| Feb 16, 2000 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters